Affiliation:
1. Center for Molecular Medicine and Infectious Diseases, Virginia-Maryland Regional College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, Virginia
2. Virginia-Maryland Regional College of Veterinary Medicine, University of Maryland, College Park, Maryland 20742
Abstract
ABSTRACTNewcastle disease virus (NDV), an avian paramyxovirus, is tumor selective and intrinsically oncolytic because of its potent ability to induce apoptosis. Several studies have demonstrated that NDV is selectively cytotoxic to tumor cells but not normal cells due to defects in the interferon (IFN) antiviral responses of tumor cells. Many naturally occurring strains of NDV have an intact IFN-antagonistic function and can still replicate in normal human cells. To avoid potential toxicity issues with NDV, especially in cancer patients with immunosuppression, safe NDV-oncolytic vectors are needed. We compared the cell killing abilities of (i) a recombinant NDV (rNDV) strain, Beaudette C, containing an IFN-antagonistic, wild-type V protein (rBC), (ii) an isogenic recombinant virus with a mutant V protein (rBC-Edit virus) that induces increased IFN in infected cells and whose replication is restricted in normal human cells, and (iii) a recombinant LaSota virus with a virulent F protein cleavage site that is as interferon sensitive as rBC-Edit virus (LaSota V.F. virus). Our results indicated that the tumor-selective replication of rNDV is determined by the differential regulation of IFN-α and downstream antiviral genes induced by IFN-α, especially through the IRF-7 pathway. In a nude mouse model of human fibrosarcoma, we show that the IFN-sensitive NDV variants are as effective as IFN-resistant rBC virus in clearing the tumor burden. In addition, mice treated with rNDV exhibited no signs of toxicity to the viruses. These findings indicate that augmentation of innate immune responses by NDV results in selective oncolysis and offer a novel and safe virotherapy platform.
Publisher
American Society for Microbiology
Subject
Virology,Insect Science,Immunology,Microbiology
Reference46 articles.
1. Advani, A. S., and A. M. Pendergast. 2002. Bcr-Abl variants: biological and clinical aspects. Leukoc. Res.26:713-720.
2. Arora, T., G. Floyd-Smith, M. J. Espy, and D. F. Jelinek. 1999. Dissociation between IFN-alpha-induced anti-viral and growth signaling pathways. J. Immunol.162:3289-3297.
3. Bell, S., S. Hansen, and J. Buchner. 2002. Refolding and structural characterization of the human p53 tumor suppressor protein. Biophys. Chem.96:243-257.
4. Bello, M. J., J. M. de Campos, M. E. Kusak, J. Vaquero, J. L. Sarasa, A. Pestana, and J. A. Rey. 1994. Allelic loss at 1p is associated with tumor progression of meningiomas. Genes Chromosomes Cancer9:296-298.
5. Bian, H., P. Fournier, B. Peeters, and V. Schirrmacher. 2005. Tumor-targeted gene transfer in vivo via recombinant Newcastle disease virus modified by a bispecific fusion protein. Int. J. Oncol.27:377-384.
Cited by
70 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献